Global Swine Pseudorabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Swine Pseudorabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Biological products for preventing pseudorabies in pigs
Swine Pseudorabies Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Pseudorabies Vaccine market is projected to reach US$ 752.1 million in 2029, increasing from US$ 568 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Demand from Farms and Individual are the major drivers for the industry.
The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Pseudorabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer
Segment by Type
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies Vaccine, Inactivated
Farms
Individual
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Pseudorabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Pseudorabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Pseudorabies Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Swine Pseudorabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Pseudorabies Vaccine introduction, etc. Swine Pseudorabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Swine Pseudorabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Swine Pseudorabies Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Pseudorabies Vaccine market is projected to reach US$ 752.1 million in 2029, increasing from US$ 568 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Demand from Farms and Individual are the major drivers for the industry.
The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Pseudorabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer
Segment by Type
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies Vaccine, Inactivated
Segment by Application
Farms
Individual
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Pseudorabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Pseudorabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Pseudorabies Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Swine Pseudorabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Pseudorabies Vaccine introduction, etc. Swine Pseudorabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Swine Pseudorabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices